Clinical trial Recruiting at 3 sites Interventional Ages 8 and up

Contact lens lubricant for rigid gas-permeable (OK) lens wearers

Official title: A Prospective, Multi-center, Open-Label, Randomized Controlled, Non-Inferiority Clinical Study Evaluating the Efficacy and Safety of Contact Lens Lubricant in Rigid Gas Permeable Corneal Contact Lens Wearers

Run by Avizor SA · NCT07091825 · Data updated 2026-11-12

This trial will test whether LACRIFRESH OCU-DRY 0.3% eye drops help rigid gas-permeable (OK) contact lens wearers feel more comfortable and keep good distance vision.

More Myopia trials

Quick facts

Study typeInterventional
Ages8 Years and up
SexAll
Enrollment152 (estimated)
SponsorAvizor SA
Industry-sponsored
Locations3 sites (Beijing, Beijing Municipality and 2 other locations)
StatusRecruiting
StartedJune 27, 2025
Main results expectedMarch 30, 2026
Study endsJune 30, 2026
Registry record updatedJuly 29, 2025
Trial IDNCT07091825 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

People aged 8 or older who currently wear rigid gas-permeable (OK) corneal contact lenses, meet vision criteria, can follow the protocol, and provide informed consent are ideal candidates.

Probably not a fit

Patients with ocular diseases that affect contact lens wear (such as keratoconus, active conjunctivitis, glaucoma), systemic conditions affecting the eyes, or known allergies to product components are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a multi-center, randomized, open-label, positive parallel-controlled trial enrolling about 152 rigid gas-permeable corneal (OK) contact lens wearers. Participants are randomly assigned to treatment groups and provided with lenses, lubricants, and care solutions as specified by the protocol. Clinical follow-up visits are scheduled at 1 week, 1 month, and 3 months after starting use to monitor safety and outcomes. Primary efficacy indexes include the percentage of patients with binocular comfort score ≥ Level 3 at 1 month and the percentage with maintained best-corrected distance visual acuity.

Why it matters

Potential benefit: If successful, the lubricant could improve wearing comfort for rigid gas-permeable lens users while preserving distance vision.

How similar studies have gone: Lubricant eye drops have shown symptom relief in other contact lens populations, but there is limited published evidence specifically for rigid gas-permeable/orthokeratology wearers.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Aged 8 and older, no gender limitation;
2. Rigid gas permeable corneal contact lens (OK lens) wearers;
3. The best corrected distance visual acuity of framed lenses in both eyes can reach 5.0 (5-Point Scale);
4. Be able and willing to comply with all treatments and follow-ups;
5. Be able to understand the purpose of the trial, participate voluntarily and have ICF signed by the subject himself/herself or his/her legal guardian.

Exclusion Criteria:

1. Patients with only one eye meeting the inclusion criteria.
2. Patients with abnormal clinical abnormalities or systemic diseases affecting the eyes that occurred or is occurring before screening and, in the investigator's judgment, preclude the use of corneal contact lenses.
3. Patients with some eye diseases that affect contact lens wearing: such as acute or chronic eye diseases, conjunctivitis catarrhalis aestiva, glaucoma, corneal abnormalities, keratoconus, etc.
4. Patients with allergies to the components of contact lens or contact lens care solution involved in this trial;
5. Patients who are using or need to use drugs that may cause dry eyes or affect vision and corneal curvature (e.g. immunosuppressant, glucocorticoids, IOP-lowering drugs, low concentration atropine) during the study;
6. Patients with a history of intraocular operation;
7. Patients with abnormal IOP (the single eye IOP \<10 mmHg or \>21mmHg, or the IOP difference of both eyes \>5mmHg), obvious fundus abnormalities, examination of corneal endothelial cell (abnormal ≥ Level 4), or slit-lamp examination abnormalities.
8. Patients with dry eye syndrome or with break up time (BUT) \<5s.
9. Subjects who participated in other drug clinical trials within 90 days before screening, and participated in other medical device clinical trials within 30 days;
10. Patients who wore rigid contact lens (including orthokeratology lens) within the past 30 days;
11. Patients who are pregnant, nursing or planning to conceive at the enrollment;
12. Patients with contraindications for wearing rigid contact lenses or unsuitable for wearing rigid contact lenses as indicated by examination results;
13. Other conditions for which the investigator judged the patient unsuitable for inclusion.

Where it's running

  • Beijing Aier Intech Eye Hospital
    Beijing, Beijing Municipality, China
    Recruiting
  • Tianjin Eye Hospital
    Tianjin, Tianjin Municipality, China
    Recruiting
  • Tianjin Medical University Eye Hospital
    Tianjin, Tianjin Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.